← Back to Search

One group pilot for Childhood Asthma

N/A
Waitlist Available
Led By Colleen McGovern, PhD
Research Sponsored by University of North Carolina, Greensboro
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Child has a diagnosis of asthma or reactive airway and prescribed a controller medication or have intermittent symptoms
The consenting parent/caregiver has at least equal responsibility for the day-to-day management of the child's asthma.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from baseline to post-intervention (8-weeks) and at 16 weeks post-intervention.
Awards & highlights

Study Summary

This trial will test an 8-session intervention for children with asthma and anxiety or depression. The goal is to see if it is feasible and acceptable.

Eligible Conditions
  • Childhood Depression
  • Childhood Asthma
  • Childhood Anxiety

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from baseline to post-intervention (8-weeks) and at 16 weeks post-intervention.
This trial's timeline: 3 weeks for screening, Varies for treatment, and from baseline to post-intervention (8-weeks) and at 16 weeks post-intervention. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Acceptability of the Intervention - for the Child Participants
Acceptability of the Intervention - for the Parent/Caregiver Participants
Acceptability related to the Intervention
+1 more
Secondary outcome measures
Anxiety Measure (Screen for Child Anxiety Related Disorders [SCARED]) - Child
Asthma Control Test - Combined Child and Parent/Caregiver
Asthma Illness Representations - Child Version (AIRS-C)
+5 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: One group pilotExperimental Treatment1 Intervention
The experimental group will receive the intervention, which is an 8-week (30 minute session per week) asthma educational and cognitive behavioral skills program.

Find a Location

Who is running the clinical trial?

University of North Carolina, GreensboroLead Sponsor
30 Previous Clinical Trials
16,577 Total Patients Enrolled
Sigma Theta Tau InternationalOTHER
2 Previous Clinical Trials
118 Total Patients Enrolled
Colleen McGovern, PhDPrincipal Investigator - University of North Carolina, Greensboro
University of North Carolina, Greensboro

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there currently any openings to join this research endeavor?

"Inaccordance to data from clinicaltrials.gov, this trial is not currently accepting patients for enrollment. The initial post was on September 1st 2019 and the last update occured on November 5th 2022. Despite this, there are 1907 other medical studies actively recruiting participants at present."

Answered by AI

What is the objective of this clinical experiment?

"The primary purpose of this 8 week trial is to gauge the viability of a specific intervention. Secondary assessments include evaluating participants' anxiety levels with the SCARED measure, AIRS-C scale exploring potential barriers in medication compliance, and CASE scale which assesses children's confidence in managing their asthma symptoms."

Answered by AI

Does this clinical trial accept participants who are older than 25 years of age?

"This medical study is exclusively recruiting patients aged 8 to 12 years old. Comparatively, there are 387 trials for minors and 1355 studies open to seniors above 65 years of age."

Answered by AI

Do I qualify to participate in this experiment?

"For this trial enrollment, 14 children aged between 8 and 12 years old who display symptoms of depression will be chosen. The inclusion criteria also require that the participants show slightly elevated levels of anxiety or depressive symptoms during screening."

Answered by AI
~3 spots leftby Mar 2025